Depression clinical study for people with BMI 30-35

New York City NY

Description

- Are you age 18-65? - Are you currently experiencing depression? - Have you been diagnosed with Major Depressive Disorder? - Do you have body-mass index between 30 and 35? You may be eligible to participate in the open-label RELIANCE-OLS one year long clinical study. REL-1017 is an investigational medicine currently under evaluation in Phase III clinical trials in the United States for the treatment of Major Depressive Disorder. Patients who are taking antidepressants and patients who are not taking antidepressants may enroll into this study. REL-1017 works differently when compared to other medications currently available to treat depression. REL-1017 is not currently approved by FDA for any condition. The Investigational medication, study supplies, study visits, and any test costs are provided at no cost. Participants in the RELIANCE studies receive reimbursement for travel expenses. If you consider the participation, please reply to this email, and we will get in touch with you.